Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33)
| קרן | National Institute of Allergy and Infectious Diseases/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 28/07/2020 |
| פקולטה | Life Sciences, Medicine |
| תיאור | The purpose of this grant is to stimulate new and innovative multidisciplinary research in the area of long acting therapeutics for HIV and HIV-associated tuberculosis (TB) and viral hepatitis B and C. Applications are sought that lead to new effective therapies for administration once per month or less frequently.
Funding: No fixed limit Duration: 5 years
Research Authority due date: 22.6.20 LOI (encourgaed) due date: 29.6.20 Full proposal due date: 29.7.20
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 24/03/2020 |
